Health Care Counsel Blog
808 total results. Page 20 of 33.
D. Jacques Smith, Stephanie Trunk, Randall A. Brater, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel
Headlines that Matter for Companies and Executives in Regulated Industries
Stephanie Trunk
On March 28, 2019 CMS issued the Final Rule and Interim Final Rule with Comment Period: Medicaid Program; Covered Outpatient Drug; Finalization of Line Extension Definition; and Change to the Rebate Calculation for Line Extension Drugs.
D. Jacques Smith, Stephanie Trunk, Randall A. Brater, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel
Headlines that Matter for Companies and Executives in Regulated Industries
D. Jacques Smith, Randall A. Brater, Peter R. Zeidenberg, Michael F. Dearington
As a matter of first impression, the US Court of Appeals for the Fourth Circuit recently held that the government’s decision to decline to intervene in a civil False Claims Act suit brought by a private relator does not preclude the government from bringing criminal fraud charges against the same de
Alexandra M. Romero
In a groundbreaking decision, the Occupational Safety and Health Review Commission on March 4, 2019 ruled for the first time that the Occupational Safety and Health Act’s (OSH Act) general duty clause obligates employers to protect their workers from workplace violence.
D. Jacques Smith, Stephanie Trunk, Randall A. Brater, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel
Headlines that Matter for Companies and Executives in Regulated Industries
D. Jacques Smith, Stephanie Trunk, Randall A. Brater, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel
Headlines that Matter for Companies and Executives in Regulated Industries
David S. Greenberg
After announcing in December that it would intervene in a qui tam action under the False Claims Act against Sutter Health and Palo Alto Medical Foundation (PAMF), the US Department of Justice filed its complaint-in-intervention in the Northern District of California on March 4, 2019.
D. Jacques Smith, Stephanie Trunk, Randall A. Brater, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel
Headlines that Matter for Companies and Executives in Regulated Industries
Douglas A. Grimm, Hillary M. Stemple
Health Care Partner Douglas Grimm and Associate Hillary Stemple authored an article for the March 2019 edition of Compliance Today titled “Telemedicine: A review of the fraud and abuse landscape.”
D. Jacques Smith, Stephanie Trunk, Randall A. Brater, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel
Headlines that Matter for Companies and Executives in Regulated Industries
D. Jacques Smith, Stephanie Trunk, Randall A. Brater, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel
Headlines that Matter for Companies and Executives in Regulated Industries
Stephanie Trunk
On February 19, 2019, the Supreme Court of the United States denied a request from Maryland’s Attorney General to review the decision of the Fourth Circuit Court of Appeals, which held the state’s drug price gouging law to be unconstitutional.
D. Jacques Smith, Stephanie Trunk, Randall A. Brater, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel
Headlines that Matter for Companies and Executives in Regulated Industries
Paul R. Lynd
California is one of a handful of states requiring employers to pay a certain minimum to employees as reporting time, or “show up,” pay.
Sarah G. Benator, Lowell C. Brown
California hospitals, medical staffs, and medical groups, take note: In addressing an issue that has been debated for years, the California Court of Appeal has concluded that a hospital’s directive to a group in a “closed” department to not schedule a practitioner due to competency issues constitute
D. Jacques Smith, Stephanie Trunk, Randall A. Brater, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel
Headlines that Matter for Companies and Executives in Regulated Industries
Stephanie Trunk
The Department of Health and Human Services Office of Inspector General has released a proposed rule (the Proposed Rule) that would make significant changes to an often relied upon Anti-Kickback Statute regulatory “safe harbor” – the Discount Safe Harbor – pursuant to which pharmaceutical manufactur
D. Jacques Smith, Stephanie Trunk, Randall A. Brater, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel
Headlines that Matter for Companies and Executives in Regulated Industries
D. Jacques Smith, Stephanie Trunk, Randall A. Brater, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel
Headlines that Matter for Companies and Executives in Regulated Industries
Caroline Turner English, Rebecca W. Foreman
In a long-awaited opinion, the Eighth Circuit Court of Appeals struck a blow to UnitedHealth Group. Inc.’s (“United”) sweeping overpayment recovery scheme.
D. Jacques Smith, Stephanie Trunk, Randall A. Brater, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel
Headlines that Matter for Companies and Executives in Regulated Industries
D. Jacques Smith, Randall A. Brater, Michael F. Dearington
On January 7, the US Supreme Court declined to review United States ex rel. Campie v. Gilead Sciences, Inc., 862 F.3d 890 (9th Cir. 2017), leaving in place a plaintiff-friendly decision by the Ninth Circuit regarding the False Claims Act’s materiality requirement.
D. Jacques Smith, Stephanie Trunk, Randall A. Brater, David S. Greenberg, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel
Headlines that Matter for Companies and Executives in Regulated Industries
Stephanie Trunk
The end of 2018 saw good news for hospitals affected by the lowered Medicare Part B reimbursement rates for certain outpatient drugs that went into effect January 1, 2018.